Ellen de Brabander - 03 Mar 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Executive Vice President, Research, Development and Regulatory Affairs
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander
Issuer symbol: ELAN
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Mar 2026, 16:12:39 UTC
Previous filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
de Brabander Ellen	Executive Vice President, Research, Development and Regulatory Affairs	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander	05 Mar 2026	0001892179

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Tax liability		-8,262	-3.1%	$24.88^*	260,124	03 Mar 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Executive Vice President, Research, Development and Regulatory Affairs